Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

NCT00171340 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1065

Enrollment

INDUSTRY

Sponsor class

Conditions

Bone Loss
Breast Cancer

Interventions

DRUG: Zoledronic acid
DRUG: Letrozole

Sponsor

Novartis Pharmaceuticals